Operating Lease, Payments in USD of Gossamer Bio, Inc. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Gossamer Bio, Inc. quarterly/annual Operating Lease, Payments history and change rate from Q1 2019 to Q3 2025.
  • Gossamer Bio, Inc. Operating Lease, Payments for the quarter ending 30 Sep 2025 was $400,000.000, a 42.9% decline year-over-year.
  • Gossamer Bio, Inc. Operating Lease, Payments for the twelve months ending 30 Sep 2025 was $2,700,000.000, a 22.9% decline year-over-year.
  • Gossamer Bio, Inc. annual Operating Lease, Payments for 2024 was $3,800,000.000, a 15.2% increase from 2023.
  • Gossamer Bio, Inc. annual Operating Lease, Payments for 2023 was $3,300,000.000, a 3.13% increase from 2022.
  • Gossamer Bio, Inc. annual Operating Lease, Payments for 2022 was $3,200,000.000, a 20% decline from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

Gossamer Bio, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $2,700,000 $400,000 -$300,000 -42.9% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $3,000,000 $400,000 -$700,000 -63.6% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 $3,700,000 $800,000 -$100,000 -11.1% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $3,800,000 $1,100,000 +$300,000 +37.5% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025
Q3 2024 $3,500,000 $700,000 +$100,000 +16.7% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 $3,400,000 $1,100,000 +$300,000 +37.5% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025
Q1 2024 $3,100,000 $900,000 -$200,000 -18.2% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 $3,300,000 $800,000 -$300,000 -27.3% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 $3,600,000 $600,000 +$100,000 +20% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 $3,500,000 $800,000 $0 0% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 $3,500,000 $1,100,000 +$300,000 +37.5% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 $3,200,000 $1,100,000 +$300,000 +37.5% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 $2,900,000 $500,000 -$500,000 -50% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $3,400,000 $800,000 -$300,000 -27.3% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 $3,700,000 $800,000 -$300,000 -27.3% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 $4,000,000 $800,000 -$200,000 -20% 01 Oct 2021 31 Dec 2021 10-K 17 Mar 2023
Q3 2021 $4,200,000 $1,000,000 $0 0% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 $4,200,000 $1,100,000 +$300,000 +37.5% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 $3,900,000 $1,100,000 +$300,000 +37.5% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 $3,600,000 $1,000,000 +$600,000 +1.5% 01 Oct 2020 31 Dec 2020 10-K 03 Mar 2022
Q3 2020 $3,000,000 $1,000,000 +$300,000 +42.9% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 $2,700,000 $800,000 +$100,000 +14.3% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021
Q1 2020 $2,600,000 $800,000 -$400,000 -33.3% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 $3,000,000 $400,000 01 Oct 2019 31 Dec 2019 10-K 26 Feb 2021
Q3 2019 $700,000 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 $700,000 01 Apr 2019 30 Jun 2019 10-Q 08 Aug 2019
Q1 2019 $1,200,000 01 Jan 2019 31 Mar 2019 10-Q 14 May 2019

Gossamer Bio, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $3,800,000 +$500,000 +15.2% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025
2023 $3,300,000 +$100,000 +3.1% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025
2022 $3,200,000 -$800,000 -20% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024
2021 $4,000,000 +$400,000 +11.1% 01 Jan 2021 31 Dec 2021 10-K 17 Mar 2023
2020 $3,600,000 +$600,000 +20% 01 Jan 2020 31 Dec 2020 10-K 03 Mar 2022
2019 $3,000,000 01 Jan 2019 31 Dec 2019 10-K 26 Feb 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.